SCHEMBL24499935

SCHEMBL24499935

O=C(O)c1cncc(-c2ccc3c(c2)CCO3)n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G10 O15496 1/20 0.59
▸ RAB9A P51151 4/20 0.49
▸ NPC1 O15118 3/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ DYRK1A Q13627 2/20 0.49
▸ MAPT P10636 2/20 0.49
▸ CYP11B2 P19099 2/20 0.48
▸ PLAU P00749 1/20 0.46
▸ FABP4 P15090 5/20 0.45
▸ CLK1 P49759 1/20 0.44
▸ PRKAB2 O43741 1/20 0.43
▸ PRKAG1 P54619 1/20 0.43
▸ PRKAA2 P54646 1/20 0.43
▸ PRKAA1 Q13131 1/20 0.43
▸ PRKAG3 Q9UGI9 1/20 0.43
▸ PRKAG2 Q9UGJ0 1/20 0.43
▸ PRKAB1 Q9Y478 1/20 0.43
▸ ERN1 O75460 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16767389 0.75 PLA2G10 (0.60) PLA2G10RAB9ANPC1SMN1; SMN2DYRK1A
SCHEMBL1328163 0.74 PLA2G10 (1.00) PLA2G10RAB9ANPC1SMN1; SMN2MAPT
SCHEMBL15999120 0.72 PLA2G10 (0.56) PLA2G10RAB9ANPC1DYRK1AFABP4
SCHEMBL5151890 0.72 DHODH (0.69) RAB9ANPC1SMN1; SMN2MAPTKDM4E
SCHEMBL2467813 0.71 DYRK1A (0.54) PLA2G10RAB9ANPC1SMN1; SMN2DYRK1A
SCHEMBL5094845 0.70 KDM4E (0.52) PLA2G10RAB9ANPC1SMN1; SMN2DYRK1A
SCHEMBL31118894 0.70 CHEK1 (0.51) MAPTALDH1A1
SCHEMBL27197596 0.69 SCD5 (0.52) CYP11B2ALDH1A1
SCHEMBL6246566 0.69 PLA2G10 (0.59) PLA2G10RAB9ANPC1SMN1; SMN2DYRK1A
SCHEMBL319106 0.69 CHEK1 (0.50) SMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116724034-A 2, 3-dihydro-4H-benzo [ B ] [1,4] oxazin-4-yl (5- (phenyl) -pyridin-3-yl) methanone derivatives and similar compounds as CYP11A1 inhibitors for the treatment of prostate cancer 奥赖恩公司 2023-09-08 — — CN disclosed
WO-2022117920-A1 2,3-DIHYDRO-4H-BENZO[B][1,4]OXAZIN-4-YL)(5-(PHENYL)-PYRIDIN-3-YL)METHANONE DERIVATIVES AND SIMILAR COMPOUNDS AS CYP11A1 INHIBITORS FOR THE TREATMENT OF PROSTATE CANCER ORION CORPORATION (FI) 2022-06-09 — — WO disclosed
Send feedback